August 10, 2021 News by Marta Figueiredo, PhD Trial Will Test Mavenclad for Advanced Progressive MS After some delays due to the COVID-19 pandemic, the Phase 2/3 clinical trial evaluating whether Mavenclad (cladribine) can slow hand and arm function worsening in adults with progressive multiple sclerosis (MS) and very limited walking abilities, has recruited its first patient. The study,Ā ChariotMS (NCT04695080), aims to…
November 23, 2020 News by Marisa Wexler, MS ChariotMS to Test Mavenclad in SPMS, PPMS Patients With Little Ability to Walk An upcoming Phase 2 clinical trial, called ChariotMS, will test whether Mavenclad (cladribine) can slow a worsening of hand and arm function in people with progressive multiple sclerosis (MS) and very limited walking abilities. Patients reliant on wheelchairs or aids to walk even short distances generally have…
May 19, 2020 News by Marisa Wexler, MS Memory Immune Cells Play Key Role in Advanced MS, Study Suggests In the brains of people with advanced multiple sclerosis (MS), memory immune cells reside in the brain tissue rather than entering through the bloodstream, a new study suggests. The study, “Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions,” was published…
April 7, 2020 News by Joana Carvalho, PhD Specialist Inpatient Rehabilitation Cost-effective for MS Patients in UK, Particularly in Advanced Disease Specialist inpatient rehabilitation is a cost-effective strategy that can improve the clinical outcomes of patients with multiple sclerosis (MS), particularly those at more advanced stages of the disease, a study in the United Kingdom (U.K.) found. The study, āCost-efficiency of specialist inpatient rehabilitation for adults with…
February 4, 2019 News by Iqra Mumal, MSc MS Trust Opens ‘Advanced MS Champions’ Program to Bring Better Care to UK Patients Healthcare specialists forĀ multiple sclerosis patients in the U.K. with advanced disease and challenging needs are getting support and recognition through a new program from the MS Trust. Called theĀ Advanced MS Champions Programme, it will recognize six MS specialist “champions” working with people with advanced MS, and their families…
June 24, 2016 News by InĆŖs Martins, PhD Study Finds PoNS Neurostimulator Plus Physical Therapy of Benefit to Advanced MS Patients Helius Medical Technologies announced results of a pilot study, demonstrating the benefits ofĀ PoNS Therapy ā aĀ combination of the investigational Portable Neuromodulation Stimulator (PoNS) device with physical therapy ā in patients with advanced multiple sclerosis (MS). Specifically, the treatmentĀ was seen to improve both patients’ quality of life, andĀ physical and…